Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mercurius corrosivus is a homeopathic remedy prepared from mercury(II) chloride (mercuric chloride) through the process of potentization, which involves serial dilution and succussion. In traditional homeopathy, it is primarily indicated for intense inflammatory conditions of the mucous membranes, particularly those involving ulceration and burning pains in the gastrointestinal and urinary tracts, such as severe dysentery, tenesmus, and cystitis. Recent experimental research has focused on its potential "bioresilience" effects, investigating whether high homeopathic potencies (e.g., 30cH or 30x) can mitigate the toxic impact of mercury chloride in biological models like brine shrimp (*Artemia salina*) and duckweed (*Lemna gibba*). These studies suggest that the remedy may influence the bioavailability of toxins or enhance natural protective processes, although conventional cell-free in vitro assays have not consistently demonstrated effects on specific enzymes like alpha-amylase.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on mercurius corrosivus.